Roundhill GLP-1 & Weight Loss ETF (OZEM) Dividend History

Dividend Yield: 0.20%
Dividend Frequency: Annually

Dividend History

Pay Date Amount Ex Dividend Date Record Date
December 31, 2024 $0.05 12/30/2024 12/30/2024

Company News

  • Best ETF Areas of Last Week

    Wall Street was upbeat last week.

    Zacks Investment Research
    Featured Companies: AAPL DAPP LLY LRNZ NVDA SMH UNG UNL WGMI
  • ETFs Bet High On Weight Loss Drugs, But Industry Observers Question Long-Term Potential

    With more than 10% of the global population now suffering from obesity, the share prices of companies providing the latest weight-loss drugs have surged. However, according to industry observers, investors considering exposure through the newly launched weight-loss exchange-traded funds (ETFs) need to evaluate their potential. The Roundhill GLP-1 Weight Loss ETF (NASDAQ:OZEM) and the Amplify Weight Loss Drug and Treatment ETF (NYSE:THNR) debuted on May 21 with an expense ratio of 0.59%. Both ETFs have significant weightings in industry giants Eli Lilly And Co (NYSE:LLY) and Novo Nordisk A/S (NYSE:NVO), with OZEM and THNR allocating about 40% and 30%, respectively, to these companies. Eli Lilly and ...Full story available on Benzinga.com

    Benzinga
    Featured Companies: LLY THNR
Page data last updated 07/23/2025 18:39:17 UTC Dividend yield is calculated using only dividends that have already been paid. Future or declared dividends are not included